Related Experiment Videos
Active site localization in a viral mRNA capping enzyme.
1Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854-5638.
The Journal of Biological Chemistry
|May 5, 1990
Summary
Reovirus mRNA capping is performed by the guanylyltransferase lambda 2. This enzyme forms a covalent complex, with the active site localized to lysine 226.
Area of Science:
- Virology
- Molecular Biology
- Enzymology
Background:
- Reovirus mRNA capping is essential for viral gene expression.
- This process is catalyzed by the virion structural polypeptide lambda 2, a guanylyltransferase.
- The enzyme forms a phosphoamide-linked enzyme-pG covalent complex as a reaction intermediate.
Purpose of the Study:
- To identify the nucleotide attachment site on the lambda 2 guanylyltransferase.
- To pinpoint the specific amino acid residue involved in the capping reaction intermediate.
Main Methods:
- Incubation of reovirus particles with [alpha-32P]GTP.
- Proteolytic cleavage of labeled virus particles.
- Analysis of fragments using sequence-directed antibodies.
- Alkali digestion, oxidation, and beta-elimination of the labeled intermediate.
Main Results:
- The nucleotide attachment site was localized to amino acids 213-269 of lambda 2.
- This region contains potential GMP acceptors: one lysine, one arginine, and four histidine residues.
- Phospholysine was identified as the sole phosphoamino acid in the intermediate, indicating lysine 226 as the active site.
Conclusions:
- The active site of the reovirus guanylyltransferase lambda 2 is localized to a region containing lysine 226.
- This lysine residue is covalently modified during the formation of the enzyme-pG intermediate.
- These findings elucidate the catalytic mechanism of reovirus mRNA capping.